Summit Therapeutics Inc (NAS:SMMT)
$ 20.37 -0.39 (-1.88%) Market Cap: 15.02 Bil Enterprise Value: 14.91 Bil PE Ratio: 0 PB Ratio: 34.53 GF Score: 30/100

Summit Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 16, 2022 / 05:00PM GMT
Release Date Price: $0.985 (-0.15%)
Operator

Good Morning and welcome to the 2022 annual meeting of shareholders of Summit Therapeutics Inc. We do not expect any technical difficult today, however, in the event that we lose the webcast connection and we are unable to provide any updates, please wait up to 10 minutes for resolution. Please refer to the Company's Investor Relations website for updates. At this time I would like to introduce Summit's Chairman and Chief Executive Officer, Bob Duggan. Thank you and over to you, sir.

Bob Duggan
Summit Therapeutics Inc. - Executive Chairman & CEO

Thank you and good morning and afternoon, ladies and gentlemen. It is my pleasure to welcome each of you to the 2022 Annual Shareholders Meeting for Summit Therapeutics and to call this meeting to order. Attending this meeting virtually is [Jeff Heyman], representing PricewaterhouseCoopers LLP, the independent registered public accounting firm for us for fiscal year 2022, subject to shareholder ratification at this meeting.

Finally, from our management team today, we have Dr. Maky Zanganeh, our Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot